Show simple item record

dc.contributor.authorLeader, Joshua
dc.contributor.authorKanji, Rahim
dc.contributor.authorGorog, Diana
dc.date.accessioned2024-05-09T13:45:00Z
dc.date.available2024-05-09T13:45:00Z
dc.date.issued2024-03-12
dc.identifier.citationLeader , J , Kanji , R & Gorog , D 2024 , ' Spontaneous Reperfusion in STEMI: its mechanisms and possible modulation ' , Polish Heart Journal (Kardiologia Polska) , vol. 82 , no. 4 , 99737 , pp. 363-374 . https://doi.org/10.33963/v.phj.99737
dc.identifier.issn1897-4279
dc.identifier.urihttp://hdl.handle.net/2299/27857
dc.description© 2024 The Author(s). This is an open access article under the Creative Commons Attribution-NonCommercial-NoDerivatives CC BY-NC-ND licence, https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.description.abstractPatients with transient ST-segment elevation myocardial infarction or spontaneous reperfusion, which occurs in approximately 20% of patients with ST-segment elevation myocardial infarction (STEMI), have smaller infarcts and more favorable clinical outcomes than patients without spontaneous reperfusion. Understanding the mechanisms underlying spontaneous reperfusion is therefore important since this may identify possible novel therapeutic targets to improve outcomes in patients with STEMI. In this review, we discuss some of the possible determinants of spontaneous reperfusion including pro-thrombotic profile, endogenous fibrinolytic status, lipoprotein(a) (Lp[a]), inflammatory markers, and neutrophil extracellular traps (NETs). Effective (rapid) endogenous fibrinolysis, as assessed in whole blood in vitro, using a point-of-care technique assessment of global thrombotic status, has been strongly linked to spontaneous reperfusion. Lp(a), which has a high degree of homology to plasminogen, may impair fibrinolysis through competitive inhibition of tissue plasminogen activator-mediated plasminogen activation as well as tissue plasminogen activator-mediated clot lysis and contribute to pathogenic clot properties by decreasing fibrin clot permeation. NETs appear to negatively modulate clot lysis by increasing thrombin fiber diameter and inhibiting plasmin-driven lysis of plasma clots. There are limited data that oral anticoagulation may modulate endogenous fibrinolysis but antiplatelet agents currently appear to have no impact. Phase III trials involving subcutaneous P2Y 12 or glycoprotein IIb/IIIa inhibitors, oral factor XIa inhibitors, interleukin-6 inhibitors, and apolipoprotein(a) antisense oligonucleotides in patients with cardiovascular disease are ongoing. Future studies will be needed to determine the impact of these novel antithrombotic, anti-inflammatory, and lipid-lowering therapies on endogenous fibrinolysis and spontaneous reperfusion.en
dc.format.extent12
dc.format.extent399653
dc.language.isoeng
dc.relation.ispartofPolish Heart Journal (Kardiologia Polska)
dc.subjectacute coronary syndrome
dc.subjectendogenous fibrinolysis
dc.subjectglobal thrombosis test
dc.subjectlipoprotein(a)
dc.subjectspontaneous reperfusion
dc.subjectCardiology and Cardiovascular Medicine
dc.titleSpontaneous Reperfusion in STEMI: its mechanisms and possible modulationen
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85191998717&partnerID=8YFLogxK
rioxxterms.versionofrecord10.33963/v.phj.99737
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record